ZYDUSWELL
Zydus Wellness share price & financials
- Price
- ₹512.35
- Market cap
- ₹16.1k Cr
- Sector
- Fast Moving Consumer Goods
- Calls analysed
- 6
Zydus Wellness Limited Q1 FY27
What went well
- Consolidated net sales grew by 66.7% YoY to ₹1,429.9 crores, driven by resilient consumer demand and a shift towards higher-value products.
- EBITDA grew by 55.3% to ₹241.7 crores, with overall EBITDA percentage expanding by approximately 0.4% on a like-to-like basis.
- International business, including Comfort Click, delivered a strong like-to-like growth of 24.8%.
What to watch
- Seasonal brands declined by 12% due to unseasonal summer showers, particularly impacting Nycil and Glucon-D in key Eastern and Northern markets.
- Reported net profit declined by 7% during the quarter, despite growth when excluding amortization of acquired brands.
What Zydus Wellness Limited does
Zydus Wellness Limited manufactures and markets a portfolio of health, nutrition and personal-care brands across two core segments, Food & Nutrition and Personal Care, earning through sale of packaged consumer products via general trade, modern trade, e-commerce and quick-commerce channels in India and overseas. Its own production is backed by third-party (3P) manufacturers in India and abroad, and it has grown through acquisitions such as Heinz India (Complan, Glucon-D, Nycil), Carnation Nutra Science (RiteBite Max Protein) and, internationally, Comfort Click/Alidac UK (WeightWorld, Animigo, maxmedix). The company sources agricultural inputs such as milk directly and indirectly from a farmer network and distributes products through a multi-tier network of distributors, wholesalers and direct retail outreach.
Segments
- Food & Nutrition
- Personal Care
- Manufacturing facilities in India
- 4
- Third-party (3P) contract manufacturers
- 23 (3 international + 20 domestic)
- Employees
- 1,500+
- Distributors
- 1,950+
- Retail stores reached
- ~2.8 million
- Feet-on-street sales representatives
- 2,700+
Guidance record · Q1 FY27
what the last two calls moved 11 tracked 1 delivered 1 missed 9 open- Comfort Click EPS Accretion delivered said Q2 FY26 Promised: The acquisition of Comfort Click is cash EPS accretive. Q1 FY27: Promise remains achieved. Management confirmed Comfort Click continued to be EPS accretive in Q1 FY27.
- Cash Tax Payout / Tax Rate missed said Q4 FY25 Promised: FY '26 and FY '27, there won't be any cash tax payout. Q1 FY27: Promise remains missed. Management confirmed for FY27, 12-15% of the total ~25% tax rate will be a cash component, directly contradicting the original 'no cash tax payout' promise.
- Seasonal Brands Growth at risk said Q4 FY26 Promised: over three to four years, I think should be able to give us a good double-digit growth Q1 FY27: Seasonal brands declined by 12% in Q1 FY27 due to unseasonal rains, putting the long-term double-digit growth target at risk. Management noted early signs of recovery post-quarter.
All 11 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 66.9%, net profit down 7.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 493 | 462 | 913 | 861 | 650 +32% | 965 +109% | 1,485 +63% | 1,437 +67% |
| EBITDA | 20 | 15 | 190 | 156 | 23 +15% | 61 +307% | 270 +42% | 242 +55% |
| Net profit | 21 | 6 | 172 | 128 | -53 −352% | -40 −767% | 162 −6% | 119 −7% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −77.8% 1Y
1Y: ₹2,486.9 on 10 Sept 2025 → ₹552. High ₹2,551.9 (11 Sept 2025), low ₹373.5 (9 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- −1.7%
- 4 Aug
- Q4 FY26
- −1.3%
- 18 May
- Q3 FY26
- −3.7%
- 3 Feb
- Q2 FY26
- −4.1%
- 5 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 35.3% a year over 3 years, FY23 to FY26. Operating margin held at 12.9%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.6k Cr | ₹2.3k Cr | ₹2.7k Cr | ₹4.0k Cr |
| Operating profit | ₹200 Cr | ₹308 Cr | ₹380 Cr | ₹510 Cr |
| Operating margin | 12.5% | 13.2% | 14.0% | 12.9% |
| Interest | ₹11 Cr | ₹23 Cr | ₹12 Cr | ₹98 Cr |
| Depreciation | ₹19 Cr | ₹24 Cr | ₹28 Cr | ₹147 Cr |
| Net profit | ₹194 Cr | ₹266 Cr | ₹347 Cr | ₹197 Cr |
| Net margin | 12.1% | 11.4% | 12.8% | 5.0% |
| Cash from operations | ₹92 Cr | ₹246 Cr | ₹380 Cr | ₹226 Cr |
| Free cash flow | ₹47 Cr | ₹220 Cr | ₹315 Cr | ₹126 Cr |
| ROCE | 6.0% | 5.0% | 6.0% | 5.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr |
| Reserves | ₹4.5k Cr | ₹4.8k Cr | ₹5.1k Cr | ₹5.3k Cr | ₹5.6k Cr | ₹5.8k Cr |
| Borrowings | ₹550 Cr | ₹387 Cr | ₹297 Cr | ₹329 Cr | ₹3.0k Cr | ₹3.2k Cr |
| Other liabilities | ₹548 Cr | ₹461 Cr | ₹413 Cr | ₹462 Cr | ₹1.1k Cr | ₹1.2k Cr |
| Total liabilities | ₹5.7k Cr | ₹5.7k Cr | ₹5.8k Cr | ₹6.1k Cr | ₹9.9k Cr | ₹10.2k Cr |
| Fixed assets | ₹4.7k Cr | ₹4.7k Cr | ₹4.7k Cr | ₹4.7k Cr | ₹8.4k Cr | ₹8.6k Cr |
| Capital work in progress | ₹4 Cr | ₹12 Cr | ₹13 Cr | ₹10 Cr | ₹13 Cr | ₹23 Cr |
| Investments | ₹0 Cr | ₹27 Cr | ₹70 Cr | ₹78 Cr | ₹28 Cr | ₹5 Cr |
| Other assets | ₹995 Cr | ₹943 Cr | ₹1.0k Cr | ₹1.4k Cr | ₹1.4k Cr | ₹1.6k Cr |
| Total assets | ₹5.7k Cr | ₹5.7k Cr | ₹5.8k Cr | ₹6.1k Cr | ₹9.9k Cr | ₹10.2k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, DIIs trimmed −0.14 pp. The shareholder count grew 31% to 86,866.
- Promoters
- 69.6%
- FIIs
- 3.3%
- DIIs
- 19.1%
- Public
- 7.9%
Since Jun 2025
- DIIs −0.14 pp
- Public +0.09 pp
- FIIs +0.07 pp
How it drifted, 12 quarters
Over this window promoters went from 68.5% to 69.6% — +1.1 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 68.5%, FIIs 3.4%, DIIs 20.2%, Public 7.8%.Dec '23: Promoters 69.2%, FIIs 3.3%, DIIs 19.7%, Public 7.9%.Mar '24: Promoters 69.6%, FIIs 3.3%, DIIs 19.4%, Public 7.7%.Jun '24: Promoters 69.6%, FIIs 3.3%, DIIs 19.4%, Public 7.7%.Sep '24: Promoters 69.6%, FIIs 3.4%, DIIs 20.4%, Public 6.7%.Dec '24: Promoters 69.6%, FIIs 3.4%, DIIs 20.1%, Public 6.9%.Mar '25: Promoters 69.6%, FIIs 3.3%, DIIs 19.8%, Public 7.3%.Jun '25: Promoters 69.6%, FIIs 3.3%, DIIs 19.3%, Public 7.8%.Sep '25: Promoters 69.6%, FIIs 3.4%, DIIs 18.8%, Public 8.2%.Dec '25: Promoters 69.6%, FIIs 3.3%, DIIs 18.6%, Public 8.5%.Mar '26: Promoters 69.6%, FIIs 3.2%, DIIs 18.9%, Public 8.3%.Jun '26: Promoters 69.6%, FIIs 3.3%, DIIs 19.1%, Public 7.9%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Late Jasodaben Babubhai Patel newly disclosed 0.01% held
- Zydus Wellness (EU) Limited newly disclosed 0.00% held
- Zydus Wellness Trading L.L.C. newly disclosed 0.00% held
- Zydus Wellness General Trading DWC-LLC newly disclosed 0.00% held
- Zara Merger SUB Inc. newly disclosed 0.00% held
- FBC Medical newly disclosed 0.00% held
- Aptitude Orthopedie newly disclosed 0.00% held
- Zyla Life Sciences Limited newly disclosed 0.00% held
The same filing shows 1 holder trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Zydus Wellness Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Zydus Lifesciences Limited | 57.59% | unchanged |
| Zydus Family Trust(Trustee:Mr. Pankaj R. Patel,Smt. Pritiben P. Patel, Dr. Sharvil P. Patel) | 12.01% | unchanged |
| Parag Parikh Flexi Cap Fund Mutual fund | 7.33% | unchanged |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund Mutual fund | 5.91% | unchanged |
| Quant Mutual Fund - Quant Small Cap Fund Mutual fund | 4.23% | −0.10 pp |
| Late Jasodaben Babubhai Patel | 0.01% | newly disclosed |
| Pankajbhai Ramanbhai Patel(HUF,Karta:Mr. Pankaj R. Patel) | 0.00% | unchanged |
| Cadila Laboratories Private Limited | 0.00% | unchanged |
| Taraben Patel Family Will Trust(Trustee:Mr Pankaj R Patel Dr Sharvil P Patel) | 0.00% | unchanged |
| Ritaben Yatinbhai Desai | 0.00% | unchanged |
| Ayushi Rajiv Mehta jointly with Arati Rajiv Mehta | 0.00% | unchanged |
| Arati Rajiv Mehta jointly with Rajiv Vastupal Mehta | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in ZYDUSWELL
Filings to Aug 2026
0 new, 5 added, 1 trimmed, 0 sold out — net +0.15 L shares (+0.1%).
- Held by funds
- ₹980 Cr
- 7 schemes
- Biggest holder
- Nippon India Small Cap Fund
- ₹909 Cr · 1.1% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| Nippon India Small Cap Fund Nippon India Mutual Fund | ₹909 Cr | +0.13 L | Aug '16 |
| Nippon India Consumption Fund Nippon India Mutual Fund | ₹58 Cr | held | Apr '24 |
| Nippon India Nifty Smallcap 250 Index Fund Nippon India Mutual Fund | ₹8 Cr | +0.02 L | Mar '26 |
| SBI Nifty Smallcap 250 Index Fund SBI Mutual Fund | ₹4 Cr | +0.01 L | Mar '26 |
| Nippon India Nifty 500 Equal Weight Index Fund Nippon India Mutual Fund | ₹1 Cr | +0.00 L | Mar '26 |
| SBI Nifty 500 Index Fund SBI Mutual Fund | ₹0 Cr | −0.00 L | Mar '26 |
| SBI Nifty Small Cap 250 ETF SBI Mutual Fund | ₹0 Cr | +0.00 L | May '26 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Aug 2026
5 added, 1 trimmed — net +15,497 shares (+0.1%)
- Funds are sitting on
- +61%
- vs est. average cost
- Held by funds
- ₹980 Cr
- 7 schemes · ≈ 5.9% of the company
- Biggest holder
- Nippon India Small Cap Fund
- ₹909 Cr · 1.1% of that fund
Shares held by these funds +44%
Aug '23 1.85 cr shares Jul '26
All earnings calls (6)
Read the Q1 FY27 call →Learn to analyse Zydus Wellness Limited
Guides on how to read this kind of business and the numbers that matter.